**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Date of Admission: March 10, 2023
* Date of Discharge: March 20, 2023
* Age: 55
* Sex: Male
* Occupation: Retired
* Chief Complaint: Fatigue, increased thirst, and frequent urination

**Medical History:**

* Hypertension (controlled with medication)
* Hyperlipidemia (controlled with medication)
* Obesity (BMI 35 kg/mÂ²)
* Family history of type 2 diabetes (father and sister)

**Admission and Diagnosis:**

John Doe was admitted to the endocrinology unit on March 10, 2023, with complaints of fatigue, increased thirst, and frequent urination. Upon admission, he was found to have a fasting plasma glucose (FPG) level of 220 mg/dL (> 11.1 mmol/L) and a glycosylated hemoglobin (HbA1C) level of 8.5%. The patient was diagnosed with type 2 diabetes mellitus based on these laboratory results.

**Treatment and Management:**

During his hospital stay, John Doe received dietary counseling and education on carbohydrate counting, meal planning, and portion control. He was instructed to increase his physical activity to at least 150 minutes per week, including both aerobic and resistance exercises. He was also advised to monitor his blood glucose levels regularly and adjust his insulin doses accordingly.

The patient was started on metformin 500 mg twice daily, which was titrated up to 1000 mg twice daily based on his blood glucose control. His blood glucose levels remained uncontrolled, and he was subsequently started on semaglutide 2.4 mg subcutaneously once weekly. His HbA1C level decreased to 7.2% after 10 days of treatment.

**Complications and Monitoring:**

John Doe underwent a comprehensive foot examination, which revealed no evidence of sensory loss or circulatory impairment. He also had a funduscopic examination, which showed no signs of diabetic retinopathy. His urine testing for albuminuria was negative, and his serum creatinine and lipid profile were within normal limits.

**Education and Counseling:**

The patient received extensive education on diabetes management, including the causes of diabetes, symptoms and signs of hypoglycemia and hyperglycemia, and diabetic complications. He was also instructed on how to adjust his insulin doses based on blood glucose levels and carbohydrate intake. He was advised to monitor his blood glucose levels regularly and to seek medical attention if he developed any signs of hypoglycemia or hyperglycemia.

**Discharge Instructions:**

John Doe is to continue his metformin and semaglutide therapy as prescribed. He is to follow up with his primary care physician in one week for a follow-up appointment. He is also advised to attend regular professional podiatric care and to receive vaccinations against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2.

**Special Instructions:**

John Doe is to adjust his insulin doses based on blood glucose levels and carbohydrate intake. He is to monitor his blood glucose levels regularly and to seek medical attention if he develops any signs of hypoglycemia or hyperglycemia. He is also advised to increase his physical activity to at least 150 minutes per week and to include both aerobic and resistance exercises.

**Follow-up:**

John Doe is to follow up with his primary care physician in one week for a follow-up appointment. He is also advised to attend regular professional podiatric care and to receive vaccinations against Streptococcus pneumoniae, influenza virus, hepatitis B, varicella, and SARS-CoV-2.

**Discharge Medications:**

* Metformin 1000 mg twice daily
* Semaglutide 2.4 mg subcutaneously once weekly
* Insulin (dosage to be determined by primary care physician)

**Discharge Date:** March 20, 2023